Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




International Radiation Oncology Collaboration

By HospiMedica staff writers
Posted on 05 Sep 2000
Collaborating on the use of 3-D treatment planning for cancer radiotherapy are Rambam Medical Center (Haifa, Israel)and the radiology oncology department at Duke University Medical Center (Durham, NC, USA). More...
Rambam is one of four radiation oncology units in Israel and serves 2.5 million people. Rambam is also the teaching hospital for Technion, the Israel Institute of Technology.

By having a computer reconstruct computed tomography (CT) scans of a patient in three dimensions, 3-D treatment planning determines the exact shape and location of a tumor and the best way to give radiation to kill it. The best answer may include several different angles and shapes for the radiation beam, says Dr. Edward Halperin, chair of radiation oncology at Duke Comprehensive Cancer Center. The researchers are also determining the benefits and costs of each component of 3-D treatment planning.

"The power of this technique,” explains Dr. Halperin, "is that you can look at a patient from all sides. You can see the heart and lungs relative to a breast tumor, for example, and see how best to kill the tumor while sparing the healthy tissue or critical organs.”

Another research project under consideration is to test the utility of a combined CT and positron emission tomography (PET) scanner. Through the partnership, residents from Duke and Rambam can spend one-month rotations at the other institution.


Related Links:
Rambam Medical Center
Duke University Medical Center

Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Gas Consumption Analyzer
Anesthetic Gas Consumption Analyzer
ow Frequency Pulse Massager
ET10 L
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: The AI-based approach identifies lipid regions matched well with histopathology results (Photo courtesy of Hyeong Soo Nam/KAIST)

AI-Based OCT Image Analysis Identifies High-Risk Plaques in Coronary Arteries

Lipid-rich plaques inside coronary arteries are strongly associated with heart attacks and other major cardiac events. While optical coherence tomography (OCT) provides detailed images of vessel structure... Read more

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.